论文部分内容阅读
强生制药公司于2008-10-22宣布,美国FDA已经批准扩展其HIV治疗药物——Prezista的适应证,即与其他药物联用治疗从未接受过治疗的HIV感染者。Prezista(darunavir)已经获得FDA批准与其他HIV药
Johnson & Johnson Pharmaceuticals announced on October 10, 2008 that the U.S. FDA has approved the extension of Prezista’s indication of expanding its HIV treatment, the HIV-infected people who have never received treatment with other drugs. Prezista (Darunavir) has received FDA approval for other HIV drugs